Home/Filings/4/0000950170-24-076423
4//SEC Filing

Dunlop A. Sinclair 4

Accession 0000950170-24-076423

CIK 0001492422other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 7:34 PM ET

Size

9.1 KB

Accession

0000950170-24-076423

Insider Transaction Report

Form 4
Period: 2024-06-21
Transactions
  • Sale

    Common Stock

    2024-06-21$39.63/sh1,695$67,173136,998 total(indirect: Indirect Owner (Epidarex))
  • Sale

    Common Stock

    2024-06-21$39.22/sh35,305$1,384,662138,693 total(indirect: Indirect Owner (Epidarex))
Holdings
  • Common Stock

    (indirect: Indirect Owner (Masa))
    31,855
  • Common Stock

    133,518
Footnotes (5)
  • [F1]These sales were effected pursuant to a non-Rule 10b5-1 trading plan adopted by Epidarex Capital I LP on March 2, 2024.
  • [F2]This transaction was executed in multiple trades at prices ranging from $38.59 - $39.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected in footnotes (1) and (2) of this Form 4.
  • [F3]This transaction was executed in multiple trades at prices ranging from $39.59 - $39.67. The price reported above reflects the weighted average sale price.
  • [F4]The securities are held by Epidarex Capital I, LP ("Epidarex") and the reporting person, a general partner of Epidarex, may be deemed to have voting and dispositive power over the shares held by Epidarex. The reporting person disclaims beneficial ownership over the shares held by Epidarex except to the extent of his pecuniary interest therein.
  • [F5]The securities are held by MASA and the reporting person, a managing partner of MASA, may be deemed to have voting and dispositive power over the shares held by MASA. The reporting person disclaims beneficial ownership over the shares held by MASA except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001721108

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 7:34 PM ET
Size
9.1 KB